Complete the separation of the Nutrition business into an independent public company

Deadline not yet reached (430 days left)

What the company said

“Abbott expects to complete the transaction by the end of 2027, subject to customary conditions, including regulatory approvals”

SourceAbbott Laboratories Form 8-K press release, 2026-10-21
FilingSEC filing index
Deadline as statedby the end of 2027
Deadline used31 Dec 2027, the last day of the stated period
TypeTransaction
Permanent referenceKI-C-2026-ABT-019833
Cite as https://keptindex.org/c/KI-C-2026-ABT-019833/ — this address never changes.

The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 31 Dec 2027.

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Separation
Indicative materiality: Transformational rules
Action: Complete
Deliverable: Separation of Nutrition business as independent public company
Language: Expected (“expects”, “plans”)
In the company’s control: Medium
Specificity: Medium
Conditional: Yes: subject to customary conditions; subject to regulatory approvals; effectiveness of a registration statement on Form 10; final approval by the Abbott Board of Directors
Depends on: Regulatory

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Commitment recordedThe company's words were matched word for word against the filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Abbott Laboratories? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.